Literature DB >> 11161071

Modern management of oesophageal varices.

P J Gow1, R W Chapman.   

Abstract

Haemorrhage from oesophageal varices is a life threatening emergency with a mortality rate in the order of 30%-50%. In the last three decades there have been many advances in the treatment and prevention of variceal bleeding. Over recent years the introduction of new pharmaceutical agents that reduce portal pressure, endoscopic variceal ligation, transjugular intrahepatic portosystemic shunt, and the availability of liver transplantation have further increased the therapeutic options available to the physician treating this disorder. This article reviews the literature regarding therapies available in the treatment of haemorrhage from oesophageal varices and provides guidelines to aid the physicians in clinical decision making.

Entities:  

Mesh:

Year:  2001        PMID: 11161071      PMCID: PMC1741921          DOI: 10.1136/pmj.77.904.75

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  90 in total

1.  Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage.

Authors:  J Goulis; A Armonis; D Patch; C Sabin; L Greenslade; A K Burroughs
Journal:  Hepatology       Date:  1998-05       Impact factor: 17.425

2.  Sucralfate for the prevention of early rebleeding following injection sclerotherapy for esophageal varices.

Authors:  R J Polson; D Westaby; A E Gimson; P C Hayes; A J Stellon; K Hayllar; R Williams
Journal:  Hepatology       Date:  1989-09       Impact factor: 17.425

3.  Prospective comparative clinical trial with distal splenorenal and mesocaval shunts.

Authors:  F A Reichle; W F Fahmy; M Golsorkhi
Journal:  Am J Surg       Date:  1979-01       Impact factor: 2.565

4.  A clinical investigation of the portacaval shunt. V. Survival analysis of the therapeutic operation.

Authors:  F C Jackson; E B Perrin; W R Felix; A G Smith
Journal:  Ann Surg       Date:  1971-10       Impact factor: 12.969

5.  Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis.

Authors:  B Bernard; J D Grangé; E N Khac; X Amiot; P Opolon; T Poynard
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

6.  Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group.

Authors:  H O Conn; N D Grace; J Bosch; R J Groszmann; J Rodés; S C Wright; D S Matloff; G Garcia-Tsao; R L Fisher; M Navasa
Journal:  Hepatology       Date:  1991-05       Impact factor: 17.425

7.  Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis.

Authors:  M Angelico; L Carli; C Piat; S Gentile; V Rinaldi; E Bologna; L Capocaccia
Journal:  Gastroenterology       Date:  1993-05       Impact factor: 22.682

8.  Prognostic factors in upper G.I. bleeding.

Authors:  F T de Dombal; J R Clarke; S E Clamp; G Malizia; M R Kotwal; A G Morgan
Journal:  Endoscopy       Date:  1986-05       Impact factor: 10.093

9.  Does elective sclerotherapy improve the efficacy of long-term propranolol for prevention of recurrent bleeding in patients with severe cirrhosis? A prospective multicenter, randomized trial.

Authors:  O Ink; T Martin; T Poynard; M Reville; M L Anciaux; C Lenoir; J L Marill; H Labadie; C Masliah; D Perrin
Journal:  Hepatology       Date:  1992-10       Impact factor: 17.425

10.  Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage.

Authors:  J Cabrera; M Maynar; R Granados; E Gorriz; R Reyes; J M Pulido-Duque; J L Rodriguez SanRoman; C Guerra; D Kravetz
Journal:  Gastroenterology       Date:  1996-03       Impact factor: 22.682

View more
  7 in total

1.  Placement confirmation of Sengstaken-Blakemore tube by ultrasound.

Authors:  A C-M Lin; Y-H Hsu; T-L Wang; C-F Chong
Journal:  Emerg Med J       Date:  2006-06       Impact factor: 2.740

2.  Experimental study on the feasibility and safety of radiofrequency ablation for secondary splenomagely and hypersplenism.

Authors:  Quan-Da Liu; Kuan-Sheng Ma; Zhen-Ping He; Jun Ding; Xue-Quan Huang; Jia-Hong Dong
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

Review 3.  Management of gastrointestinal haemorrhage.

Authors:  S Ghosh; D Watts; M Kinnear
Journal:  Postgrad Med J       Date:  2002-01       Impact factor: 2.401

4.  Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment.

Authors:  Shiv Kumar Sarin; Ashish Kumar; Yogesh Kumar Chawla; Sanjay Saran Baijal; Radha Krishna Dhiman; Wasim Jafri; Laurentius A Lesmana; Debendranath Guha Mazumder; Masao Omata; Huma Qureshi; Rizvi Moattar Raza; Peush Sahni; Puja Sakhuja; Mohammad Salih; Amal Santra; Barjesh Chander Sharma; Praveen Sharma; Gamal Shiha; Jose Sollano
Journal:  Hepatol Int       Date:  2007-09-11       Impact factor: 6.047

Review 5.  Liver transplantation in patients with liver cirrhosis and esophageal bleeding.

Authors:  Christian Hillert; Lutz Fischer; Dieter C Broering; Xavier Rogiers
Journal:  Langenbecks Arch Surg       Date:  2003-05-20       Impact factor: 3.445

Review 6.  The clinical effectiveness of permissive hypotension in blunt abdominal trauma with hemorrhagic shock but without head or spine injuries or burns: a systematic review.

Authors:  Abdulrahman Alsawadi
Journal:  Open Access Emerg Med       Date:  2012-05-30

Review 7.  Management of Variceal Hemorrhage.

Authors:  Yan Li; Chun Qing Zhang
Journal:  Gastroenterology Res       Date:  2009-01-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.